Conditioning with melphalan 200 mg/m<sup>2</sup> and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.

Afram, Gabriel; Chaireti, Roza; Uttervall, Katarina; Luong, Vincent; Lund, Johan; Kashif, Muhammad; Gahrton, Gösta; Alici, Evren; Nahi, Hareth

Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care.

Afram, Gabriel; Chaireti, Roza; Uttervall, Katarina; Luong, Vincent; Lund, Johan; Kashif, Muhammad; Gahrton, Gösta; Alici, Evren; Nahi, Hareth.

Afiliación

Afram G; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Chaireti R; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Uttervall K; Pfizer AB, Sollentuna, Sweden.
Luong V; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Lund J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Kashif M; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Gahrton G; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Alici E; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Nahi H; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

Eur J Haematol ; 109(6): 749-754, 2022 Dec.

Article en En | MEDLINE | ID: mdl-36066204

Asunto(s)

Trasplante de Células Madre Hematopoyéticas; Mieloma Múltiple; Anciano; Humanos; Melfalán/uso terapéutico; Mieloma Múltiple/diagnóstico; Mieloma Múltiple/tratamiento farmacológico; Trasplante Autólogo; Trasplante de Células Madre Hematopoyéticas/métodos; Acondicionamiento Pretrasplante/métodos; Supervivencia sin Enfermedad; Estudios Retrospectivos; Nivel de Atención; Resultado del Tratamiento

Palabras clave

aged; multiple myeloma; progression-free survival; stem cell transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Revista: Eur J Haematol Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google